Literature DB >> 24805851

Transcriptome analysis reveals differential splicing events in IPF lung tissue.

Tracy Nance, Kevin S Smith, Vanessa Anaya, Rhea Richardson, Lawrence Ho, Mauro Pala, Sara Mostafavi, Alexis Battle, Carol Feghali-Bostwick, Glenn Rosen, Stephen B Montgomery.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a complex disease in which a multitude of proteins and networks are disrupted. Interrogation of the transcriptome through RNA sequencing (RNA-Seq) enables the determination of genes whose differential expression is most significant in IPF, as well as the detection of alternative splicing events which are not easily observed with traditional microarray experiments. We sequenced messenger RNA from 8 IPF lung samples and 7 healthy controls on an Illumina HiSeq 2000, and found evidence for substantial differential gene expression and differential splicing. 873 genes were differentially expressed in IPF (FDR<5%), and 440 unique genes had significant differential splicing events in at least one exonic region (FDR<5%). We used qPCR to validate the differential exon usage in the second and third most significant exonic regions, in the genes COL6A3 (RNA-Seq adjusted pval = 7.18e-10) and POSTN (RNA-Seq adjusted pval = 2.06e-09), which encode the extracellular matrix proteins collagen alpha-3(VI) and periostin. The increased gene-level expression of periostin has been associated with IPF and its clinical progression, but its differential splicing has not been studied in the context of this disease. Our results suggest that alternative splicing of these and other genes may be involved in the pathogenesis of IPF. We have developed an interactive web application which allows users to explore the results of our RNA-Seq experiment, as well as those of two previously published microarray experiments, and we hope that this will serve as a resource for future investigations of gene regulation in IPF.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24805851      PMCID: PMC4013141          DOI: 10.1371/journal.pone.0097550

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Notice of Republication

This article was republished on April 21, 2014, to correct the figure order. Please download the article again to view the correct version. The originally published, uncorrected article and the republished, corrected article are provided here for reference. Originally published, uncorrected article. (PDF) Click here for additional data file. Republished, corrected article. (PDF) Click here for additional data file.
  1 in total

1.  Transcriptome analysis reveals differential splicing events in IPF lung tissue.

Authors:  Tracy Nance; Kevin S Smith; Vanessa Anaya; Rhea Richardson; Lawrence Ho; Mauro Pala; Sara Mostafavi; Alexis Battle; Carol Feghali-Bostwick; Glenn Rosen; Stephen B Montgomery
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

  1 in total
  12 in total

1.  Cleavage factor 25 deregulation contributes to pulmonary fibrosis through alternative polyadenylation.

Authors:  Tingting Weng; Junsuk Ko; Chioniso P Masamha; Zheng Xia; Yu Xiang; Ning-Yuan Chen; Jose G Molina; Scott Collum; Tinne C Mertens; Fayong Luo; Kemly Philip; Jonathan Davies; Jingjing Huang; Cory Wilson; Rajarajan A Thandavarayan; Brian A Bruckner; Soma Sk Jyothula; Kelly A Volcik; Lei Li; Leng Han; Wei Li; Shervin Assassi; Harry Karmouty-Quintana; Eric J Wagner; Michael R Blackburn
Journal:  J Clin Invest       Date:  2019-02-28       Impact factor: 14.808

Review 2.  Roles of Periostin in Respiratory Disorders.

Authors:  Kenji Izuhara; Simon J Conway; Bethany B Moore; Hisako Matsumoto; Cecile T J Holweg; John G Matthews; Joseph R Arron
Journal:  Am J Respir Crit Care Med       Date:  2016-05-01       Impact factor: 21.405

3.  TGF-β1 increases sialidase 3 expression in human lung epithelial cells by decreasing its degradation and upregulating its translation.

Authors:  Wensheng Chen; Teresa M Lamb; Richard H Gomer
Journal:  Exp Lung Res       Date:  2020-02-26       Impact factor: 2.459

4.  Olodaterol shows anti-fibrotic efficacy in in vitro and in vivo models of pulmonary fibrosis.

Authors:  Franziska Elena Herrmann; Lutz Wollin; Johannes Wirth; Florian Gantner; Bärbel Lämmle; Eva Wex
Journal:  Br J Pharmacol       Date:  2017-09-20       Impact factor: 8.739

5.  Integrative analysis of DNA methylation and gene expression data identifies EPAS1 as a key regulator of COPD.

Authors:  Seungyeul Yoo; Sachiko Takikawa; Patrick Geraghty; Carmen Argmann; Joshua Campbell; Luan Lin; Tao Huang; Zhidong Tu; Robert F Foronjy; Robert Feronjy; Avrum Spira; Eric E Schadt; Charles A Powell; Jun Zhu
Journal:  PLoS Genet       Date:  2015-01-08       Impact factor: 5.917

Review 6.  Pharmacology of Modulators of Alternative Splicing.

Authors:  David O Bates; Jonathan C Morris; Sebastian Oltean; Lucy F Donaldson
Journal:  Pharmacol Rev       Date:  2017-01       Impact factor: 25.468

7.  Pathway‑based detection of idiopathic pulmonary fibrosis at an early stage.

Authors:  Guojun Zhou; Fangxia Zhang; Yufang Liu; Bin Sun
Journal:  Mol Med Rep       Date:  2017-03-01       Impact factor: 2.952

8.  Gene Expression Changes Associated with Nintedanib Treatment in Idiopathic Pulmonary Fibrosis Fibroblasts: A Next-Generation Sequencing and Bioinformatics Study.

Authors:  Chau-Chyun Sheu; Wei-An Chang; Ming-Ju Tsai; Ssu-Hui Liao; Inn-Wen Chong; Po-Lin Kuo
Journal:  J Clin Med       Date:  2019-03-05       Impact factor: 4.241

9.  RNA sequencing of transplant-stage idiopathic pulmonary fibrosis lung reveals unique pathway regulation.

Authors:  Pitchumani Sivakumar; John Ryan Thompson; Ron Ammar; Mary Porteous; Carly McCoubrey; Edward Cantu; Kandasamy Ravi; Yan Zhang; Yi Luo; Denis Streltsov; Michael F Beers; Gabor Jarai; Jason D Christie
Journal:  ERJ Open Res       Date:  2019-08-12

10.  Modeling Progressive Fibrosis with Pluripotent Stem Cells Identifies an Anti-fibrotic Small Molecule.

Authors:  Preethi Vijayaraj; Aspram Minasyan; Abdo Durra; Saravanan Karumbayaram; Mehrsa Mehrabi; Cody J Aros; Sarah D Ahadome; David W Shia; Katherine Chung; Jenna M Sandlin; Kelly F Darmawan; Kush V Bhatt; Chase C Manze; Manash K Paul; Dan C Wilkinson; Weihong Yan; Amander T Clark; Tammy M Rickabaugh; W Dean Wallace; Thomas G Graeber; Robert Damoiseaux; Brigitte N Gomperts
Journal:  Cell Rep       Date:  2019-12-10       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.